Clinical Trial Update: A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

This update notes the completion of a Phase 3 multinational, randomized, open-label study evaluating custirsen in patients with advanced or metastatic non-small…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Custirsen (custirsen)

Snippet

Sponsor: Achieve Life Sciences | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED